Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Neutralization of Mu and C.1.2 SARS-CoV-2 Variants by Vac... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Neutralization of Mu and C.1.2 SARS-CoV-2 Variants by Vaccine-elicited Antibodies in Individuals With and Without Previous History of Infection
0
Authors
Takuya Tada
7 more
Takuya Tada
•
Hao Zhou
5 more
•
Nathaniel Landau
Published
October 20, 2021
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to review
Share your thoughts on this paper...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Immunology
Medicine
Pathology
Disease
Show all topics
DOI
10.1101/2021.10.19.463727
License
cc-no
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Immunology
Medicine
Pathology
Disease
Show all topics
DOI
10.1101/2021.10.19.463727
License
cc-no